This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Teva-Ramipril (2.5 mg and 5 mg)
- Starting date:
- March 28, 2013
- Posting date:
- April 23, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-26853
Recalled Products
- Teva-Ramipril (2.5 mg)
- Teva-Ramipril (5mg)
Reason
Product stability testing shows that the lot will likely have results above its specification limit for the total impurities test before the labelled expiry date.
Depth of distribution
Lot was distributed to wholesalers and retailers in NF, QC, ON, MB, BC.
Lot was also distributed to compassionate drug programs in ON.
Affected products
A. Teva-Ramipril 2.5 mg
DIN, NPN, DIN-HIM
DIN 02247945
Dosage form
- Capsule
Strength
- 2.5 mg
Lot or serial number
- 35328352B
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
B. Teva-Ramipril 5 mg
DIN, NPN, DIN-HIM
DIN 02247946
Dosage form
- Capsule
Strength
- 5 mg
Lot or serial number
- 35328356B
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA